Aquablation therapy (AquaBeam) is a surgical procedure for men with lower urinary tract symptoms resulting from benign prostatic hyperplasia (BPH). It is in the early stages of study.[1] It is not categorized as minimally invasive as general anesthesia is required.[2] The procedure was developed by PROCEPT BioRobotics and combines real-time visualization through a cystoscope and a bi-plane ultrasound, while using a high-velocity sterile saline heat-free waterjet and autonomous robotics to remove prostate tissue.[3][4]
| Aquablation therapy | |
|---|---|
| Specialty | Urology |
A systematic review from 2019 found that for men with lower urinary tract symptoms, aquablation is probably as effective as transurethral resection of the prostate in improving urinary symptoms and may lead to a similar quality of life.[5] The evidence from this review with a 12-month follow-up is very uncertain if aquablation leads to similar rates of serious side effects or a similar need for retreatment when compared to transurethral resection of the prostate. Aquablation may lead to fewer ejaculatory problems, but no difference in erectile function. These findings were based on a single study with 184 men with a prostate size less or equal to 80 mL funded by the company that manufactures the device.[citation needed]
References
edit- ^ Pimentel MA, Nair SM, Gilling PJ (June 2016). "Aquablation - Early Clinical Results". Current Bladder Dysfunction Reports. 11 (2): 130–133. doi:10.1007/s11884-016-0364-5. S2CID 76102425.
- ^ "Benign Prostatic Hyperplasia (BPH) Guideline - American Urological Association". www.auanet.org. Archived from the original on 2021-04-20. Retrieved 2020-06-07.
- ^ Gilling P, Reuther R, Kahokehr A, Fraundorfer M (June 2016). "Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience". BJU International. 117 (6): 923–9. doi:10.1111/bju.13358. PMID 26477826. S2CID 3334967.
- ^ MacRae C, Gilling P (December 2016). "How I do it: Aquablation of the prostate using the AQUABEAM system" (PDF). The Canadian Journal of Urology. 23 (6): 8590–8593. PMID 27995858.
- ^ Hwang EC, Jung JH, Borofsky M, Kim MH, Dahm P, et al. (Cochrane Urology Group) (February 2019). "Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia". The Cochrane Database of Systematic Reviews. 2019 (2): CD013143. doi:10.1002/14651858.CD013143.pub2. PMC 6373984. PMID 30759311.